Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma

الملخص EN

Background.

Glucosamine-Phosphate N-Acetyltransferase 1 (GNPNAT1) is a critical enzyme in the biosynthesis of uridine diphosphate-N-acetylglucosamine.

It has many important functions, such as protein binding, monosaccharide binding, and embryonic development and growth.

However, the role of GNPNAT1 in lung adenocarcinoma (LUAD) remains unclear.

Methods.

In this study, we explored the expression pattern and prognostic value of GNPNAT1 in LUAD across TCGA and GEO databases and assessed its independent prognostic value via Cox analysis.

LinkedOmics and GEPIA2 were applied to investigate coexpression and functional networks associated with GNPNAT1.

The TIMER web tool was deployed to assess the correlation between GNPNAT1 and the main six types of tumor-infiltrating immune cells.

Besides, the correlations between GNPNAT1 and the LUAD common genetic mutations, TMB, and immune signatures were examined.

Results.

GNPNAT1 was validated upregulated in tumor tissues in TCGA-LUAD and GEO cohorts.

Moreover, in both TCGA and GEO cohorts, high GNPNAT1 expression was found to be associated with poor overall survival.

Cox analysis showed that high GNPNAT1 expression was an independent risk factor for LUAD.

Functional network analysis suggested that GNPNAT1 regulates cell cycle, ribosome, proteasome, RNA transport, and spliceosome signaling through pathways involving multiple cancer-related kinases and E2F family.

In addition, GNPNAT1 correlated with infiltrating levels of B cells, CD4+ T cells, and dendritic cells.

B cells and dendritic cells could predict the outcome of LUAD, and B cells and CD4+ T cells were significant independent risk factors.

The TMB and mutations of KRAS, EGFR, STK11, and TP53 were correlated with GNPNAT1.

At last, the correlation analysis showed GNPNAT1 correlated with most of the immune signatures we performed.

Conclusion.

Our findings showed that GNPNAT1 was correlated to the prognosis and immune infiltration of LUAD.

In particular, the tight relationship between GNPNAT1 and B cell marker genes may be the epicenter of the immune response and one of the key factors affecting the prognosis.

Our findings laid the foundation for further research on the immunomodulatory role of GNPNAT1 in LUAD.